Zobrazeno 1 - 10
of 309
pro vyhledávání: '"Sridharan, Gururangan"'
Autor:
James J. Vredenburgh, Henry S. Friedman, Allan H. Friedman, Darell D. Bigner, Leighann Bailey, John Sampson, Sridharan Gururangan, Sith Sathornsumetee, Jeremy N. Rich, Jennifer A. Quinn, Jennifer Marcello, James E. Herndon, David A. Reardon, Annick Desjardins
Supplementary Table S3 from Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0459b1c579da6e8c393e3f710f991df
https://doi.org/10.1158/1078-0432.22439439.v1
https://doi.org/10.1158/1078-0432.22439439.v1
Autor:
Amar Gajjar, David W. Ellison, Marcel Kool, Thomas E. Merchant, Frederick A. Boop, Kim E. Nichols, Daniel J. Indelicato, Zoltan Patay, Paul Klimo, Robert P. Sanders, Roya Mostafavi, Sridharan Gururangan, Eric Bouffet, Murali Chintagumpala, John R. Crawford, Paul G. Fisher, Sonia Partap, Tim Hassall, Anne E. Bendel, Gregory T. Armstrong, Anna Vinitsky, Ibrahim Qaddoumi, Alberto Broniscer, Ashok Srinivasan, Sandeep Kumar Dhanda, Ruth G. Tatevossian, Catherine A. Billups, Gang Wu, Pascal Johann, Brent A. Orr, Arzu Onar-Thomas, Giles W. Robinson, Santhosh A. Upadhyaya
Supplementary Figures S1 to S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::126a7d0e9a9a0e98aa4e6e8e91ef267e
https://doi.org/10.1158/1078-0432.22478771
https://doi.org/10.1158/1078-0432.22478771
Autor:
Amar Gajjar, David W. Ellison, Marcel Kool, Thomas E. Merchant, Frederick A. Boop, Kim E. Nichols, Daniel J. Indelicato, Zoltan Patay, Paul Klimo, Robert P. Sanders, Roya Mostafavi, Sridharan Gururangan, Eric Bouffet, Murali Chintagumpala, John R. Crawford, Paul G. Fisher, Sonia Partap, Tim Hassall, Anne E. Bendel, Gregory T. Armstrong, Anna Vinitsky, Ibrahim Qaddoumi, Alberto Broniscer, Ashok Srinivasan, Sandeep Kumar Dhanda, Ruth G. Tatevossian, Catherine A. Billups, Gang Wu, Pascal Johann, Brent A. Orr, Arzu Onar-Thomas, Giles W. Robinson, Santhosh A. Upadhyaya
Purpose:Report relevance of molecular groups to clinicopathologic features, germline SMARCB1/SMARCA4 alterations (GLA), and survival of children with atypical teratoid rhabdoid tumor (ATRT) treated in two multi-institutional clinical trials.Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b29fb4f16e48c14f46b5194fc53bbec
https://doi.org/10.1158/1078-0432.c.6530039
https://doi.org/10.1158/1078-0432.c.6530039
Autor:
Amar Gajjar, David W. Ellison, Marcel Kool, Thomas E. Merchant, Frederick A. Boop, Kim E. Nichols, Daniel J. Indelicato, Zoltan Patay, Paul Klimo, Robert P. Sanders, Roya Mostafavi, Sridharan Gururangan, Eric Bouffet, Murali Chintagumpala, John R. Crawford, Paul G. Fisher, Sonia Partap, Tim Hassall, Anne E. Bendel, Gregory T. Armstrong, Anna Vinitsky, Ibrahim Qaddoumi, Alberto Broniscer, Ashok Srinivasan, Sandeep Kumar Dhanda, Ruth G. Tatevossian, Catherine A. Billups, Gang Wu, Pascal Johann, Brent A. Orr, Arzu Onar-Thomas, Giles W. Robinson, Santhosh A. Upadhyaya
Germline methodology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13bef37eeec39cfa3a98bf2f3a814022
https://doi.org/10.1158/1078-0432.22478768
https://doi.org/10.1158/1078-0432.22478768
Autor:
James J. Vredenburgh, Henry S. Friedman, Allan H. Friedman, Darell D. Bigner, Leighann Bailey, John Sampson, Sridharan Gururangan, Sith Sathornsumetee, Jeremy N. Rich, Jennifer A. Quinn, Jennifer Marcello, James E. Herndon, David A. Reardon, Annick Desjardins
Purpose: Although patients with newly diagnosed WHO grade 3 malignant glioma have a more favorable prognosis than those with WHO grade 4 malignant glioma, salvage therapies following recurrence offer essentially palliative benefit. We did a phase II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3bc4c8b61c92c61495b258cf356c5f5
https://doi.org/10.1158/1078-0432.c.6516909.v1
https://doi.org/10.1158/1078-0432.c.6516909.v1
Autor:
Ira J Dunkel, François Doz, Nicholas K Foreman, Darren Hargrave, Alvaro Lassaletta, Nicolas André, Jordan R Hansford, Tim Hassall, Matthias Eyrich, Sridharan Gururangan, Ute Bartels, Amar Gajjar, Lisa Howell, Deepti Warad, Misena Pacius, Rachel Tam, Yu Wang, Li Zhu, Kenneth Cohen
Publikováno v:
Neuro-Oncology.
Background Therapeutic options are limited in pediatric CNS malignancies. CheckMate 908 (NCT03130959) is an open-label, sequential-arm, phase 1b/2 study investigating nivolumab (NIVO) and NIVO + ipilimumab (IPI) in pediatric patients with high-grade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f076d6d7f3a01fa38775d857a08f6008
https://doi.org/10.1093/neuonc/noad031
https://doi.org/10.1093/neuonc/noad031
Autor:
Sumedha Sudhaman, Noor Alsafwani, Eric Bouffet, Sridharan Gururangan, Jiil Chung, Logine Negm, Trisha Larkin, Jason E. Blatt, Uri Tabori, Anirban Das, Vanessa Bianchi, Anthony T. Yachnis, Cynthia Hawkins
Publikováno v:
JCO Precision Oncology. :1426-1431
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd64808045ef15dd70d0d022f58edf3d
https://doi.org/10.1200/po.21.00153
https://doi.org/10.1200/po.21.00153
Autor:
Jane E. Minturn, Ayman El-Sheikh, Gustavo Sevlever, Michelle Monje-Deisseroth, Hetal Dholaria, Karen Tsui, Maryam Fouladi, Pratiti Bandopadhayay, Cynthia Hawkins, Scott L Coven, Lindsay Kilburn, Christopher L. Tinkle, David S. Ziegler, Eric Sandler, Yvan Samson, Jordan R. Hansford, Eric Bouffet, Sylvia Cheng, Sridharan Gururangan, Kathleen Dorris, Tim Hassall, Mohamed S. Zaghloul, Carl Koschmann, Sarah Leary, Mercedes Garcia Lombardi, Blaise V. Jones, Paul G. Fisher, Anthony Asher, Rachid Drissi, Blanca Diez, Kenneth J. Cohen, Jie Ma, Adriana Fonseca, Katie Black, Nicholas G. Gottardo, Stewart Goldman, Christine E. Fuller, Tabitha Cooney, Moatasem El-Ayadi, Adam Lane, Brooklyn Chaney, Mariko DeWire, Robert J. Greiner, Ute Bartels, Margot A Lazow, James L. Leach, Lars M. Wagner, Roger J. Packer
Publikováno v:
Neuro Oncol
Background Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb93f7f10aea819afa4cbaa267e360e
https://doi.org/10.1093/neuonc/noab245
https://doi.org/10.1093/neuonc/noab245
Autor:
Craig Erker, Adam Lane, Brooklyn Chaney, Sarah Leary, Jane E Minturn, Ute Bartels, Roger J Packer, Kathleen Dorris, Nicholas G Gottardo, Katherine E Warren, Alberto Broniscer, Mark W Kieran, Xiaoting Zhu, Peter White, Phillip J Dexheimer, Katie Black, Anthony Asher, Mariko DeWire, Jordan R Hansford, Sridharan Gururangan, Javad Nazarian, David S Ziegler, Eric Sandler, Allison Bartlett, Stewart Goldman, Chie-Schin Shih, Tim Hassall, Hetal Dholaria, Pratiti Bandopadhayay, Yvan Samson, Michelle Monje, Paul G Fisher, Andrew Dodgshun, Sarah Parkin, Murali Chintagumpala, Karen Tsui, David Gass, Valerie Larouche, Emmett Broxson, Mercedes Garcia Lombardi, Stacie Shiqi Wang, Jie Ma, Cynthia Hawkins, Dima Hamideh, Lars Wagner, Carl Koschmann, Christine Fuller, Rachid Drissi, Blaise V Jones, James Leach, Maryam Fouladi
Publikováno v:
Neuro Oncol
BackgroundDiffuse intrinsic pontine gliomas (DIPG) generally occur in young school-age children, although can occur in adolescents and young adults. The purpose of this study was to describe clinical, radiological, pathologic, and molecular character
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2e66e41b9873afea3ba3f4519e69db9
https://doi.org/10.1093/neuonc/noab140
https://doi.org/10.1093/neuonc/noab140
Autor:
I-C Hia Liu, Sridharan Gururangan, Adam L. Holtzman, Daryoush Tavanaiepour, Daniel J. Indelicato, Robert Cavaliere, Michael S. Rutenberg, Bridgette Carter, Christopher G. Morris, Ronny L Rotondo
Publikováno v:
Journal of Neuro-Oncology. 153:467-476
We report disease control, survival outcomes, and treatment-related toxicity among adult medulloblastoma patients who received proton craniospinal irradiation (CSI) as part of multimodality therapy. We reviewed 20 adults with medulloblastoma (≥ 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b04b8b96ab218e5ba7f4ea7434c2272
https://doi.org/10.1007/s11060-021-03783-x
https://doi.org/10.1007/s11060-021-03783-x